Cryo-Cell International, Inc.CCELNYSE
Loading
EBITDA Margin Over TimeContracting
Percentile Rank29
3Y CAGR-58.9%
5Y CAGR-42.0%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
-58.9%/yr
vs +4.0%/yr prior
5Y CAGR
-42.0%/yr
Recent deceleration
Acceleration
-62.9pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.52% | -65.8% |
| 2024 | 4.45% | +113.4% |
| 2023 | -33.24% | -251.6% |
| 2022 | 21.92% | +19.1% |
| 2021 | 18.41% | -20.6% |
| 2020 | 23.18% | +34.2% |
| 2019 | 17.27% | -7.9% |
| 2018 | 18.76% | -7.6% |
| 2017 | 20.31% | +477.0% |
| 2016 | -5.39% | - |